Drug · DIN 00716863
LYDERM
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 6, 2023; first marketed December 31, 1988.
- Drug Identification Number (DIN)
- 00716863
- Company (DIN owner)
- Taropharma, A Division Of Taro Pharmaceuticals Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Fluocinonide D07AC08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLUOCINONIDE | 0.05 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 6, 2023: NOC 32282Supplement to a New Drug Submission (SNDS) · Update to the Product Monograph. Update to Labels to align with Plain Language Labelling (PLL) regulations. Product Name Change
- September 4, 2003: NOC 745New Drug Submission (NDS) · Manufacturer name change
- January 31, 2001: NOC 2280New Drug Submission (NDS) · Manufacturer name change
Other DINs named LYDERM
- DIN 02236996 · Marketed
- DIN 02236997 · Marketed